Brief: Pila Pharma H1 EBIT Loss Widens To SEK 4.1 Mln
27/08/2024 07:19
Aug 27 (Reuters) - Pila Pharma AB PILA.ST :
* H1 OPERATING INCOME AMOUNTED TO TSEK 683 (1 097)
* H1 EBIT LOSS TOTALLED TO TSEK - 4 083 (- 3 601)
* OPTIMISTIC FOR OUR COMPANY DUE TO WAY OBESITY MARKET HAS
DEVELOPED
Source text for Eikon: ID:nBQN19qgsV
Further company coverage: PILA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))